Detalles de la búsqueda
1.
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.
N Engl J Med
; 385(5): 395-405, 2021 07 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34320285
2.
Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM.
Eur J Haematol
; 102(5): 437-441, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30725494
3.
Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG).
Breast Care (Basel)
; 17(2): 137-145, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35707180
4.
Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals.
Cancer Chemother Pharmacol
; 83(2): 265-275, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30430227
5.
A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc™) in patients with locally advanced or metastatic cancer.
Cancer Chemother Pharmacol
; 82(4): 695-706, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30074076
6.
Sequential immunotherapy in a patient with primary refractory Hodgkin lymphoma and novel mutations.
Oncotarget
; 9(29): 20928-20940, 2018 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-29755699
Resultados
1 -
6
de 6
1
Próxima >
>>